SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
ROCKLAGE SCOTT M

(Last) (First) (Middle)
C/O 5AM VENTURES
2200 SAND HILL ROAD, SUITE 110

(Street)
MENLO PARK CA 94025

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
11/14/2013
3. Issuer Name and Ticker or Trading Symbol
Relypsa Inc [ RLYP ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 21,260(1) I See Footnotes(2)(4)
Common Stock 838(1) I See Footnotes(3)(4)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) (5) 07/23/2023 Common Stock 10,140(1) $7.4(1) D
Series A-1 Preferred Stock (6) (7) Common Stock 757,187(1)(8) $0.00 I See Footnotes(2)(4)
Series A-1 Preferred Stock (6) (7) Common Stock 29,876(1)(8) $0.00 I See Footnotes(3)(4)
Series B-1 Preferred Stock (6) (7) Common Stock 386,754(1)(9) $0.00 I See Footnotes(2)(4)
Series B-1 Preferred Stock (6) (7) Common Stock 15,260(1)(9) $0.00 I See Footnotes(3)(4)
Series B-2 Preferred Stock (6) (7) Common Stock 576,958(1)(10) $0.00 I See Footnotes(2)(4)
Series B-2 Preferred Stock (6) (7) Common Stock 22,765(1)(10) $0.00 I See Footnotes(3)(4)
Series C-1 Preferred Stock (6) (7) Common Stock 207,347(1)(11) $0.00 I See Footnotes(2)(4)
Series C-1 Preferred Stock (6) (7) Common Stock 8,181(1)(11) $0.00 I See Footnotes(3)(4)
Series C-1 Preferred Stock (6) (7) Common Stock 1,234,230(1)(11) $0.00 I See Footnotes(12)(14)
Series C-1 Preferred Stock (6) (7) Common Stock 31,809(1)(11) $0.00 I See Footnotes(13)(14)
Series C-2 Preferred Stock (6) (7) Common Stock 47,849(1)(15) $0.00 I See Footnotes(2)(4)
Series C-2 Preferred Stock (6) (7) Common Stock 1,888(1)(15) $0.00 I See Footnotes(3)(4)
Series C-2 Preferred Stock (6) (7) Common Stock 284,822(1)(15) $0.00 I See Footnotes(12)(14)
Series C-2 Preferred Stock (6) (7) Common Stock 7,340(1)(15) $0.00 I See Footnotes(13)(14)
Warrant to Purchase Preferred Stock (16) (17) Series B-1 Preferred Stock(18) 25,208(1) $13.502(1) I See Footnotes(2)(4)
Warrant to Purchase Preferred Stock (16) (17) Series B-1 Preferred Stock(18) 994(1) $13.502(1) I See Footnotes(3)(4)
Warrant to Purchase Preferred Stock (16) (19) Series C-1 Preferred Stock(20) 74,281(1) $0.17(1) I See Footnotes(2)(4)
Warrant to Purchase Preferred Stock (16) (19) Series C-1 Preferred Stock(20) 2,931(1) $0.17(1) I See Footnotes(3)(4)
Warrant to Purchase Preferred Stock (16) (19) Series C-1 Preferred Stock(20) 442,160(1) $0.17(1) I See Footnotes(12)(14)
Warrant to Purchase Preferred Stock (16) (19) Series C-1 Preferred Stock(20) 11,395(1) $0.17(1) I See Footnotes(13)(14)
Warrant to Purchase Preferred Stock (16) (19) Series C-2 Preferred Stock(21) 17,141(1) $0.17(1) I See Footnotes(2)(4)
Warrant to Purchase Preferred Stock (16) (19) Series C-2 Preferred Stock(21) 676(1) $0.17(1) I See Footnotes(3)(4)
Warrant to Purchase Preferred Stock (16) (19) Series C-2 Preferred Stock(21) 102,036(1) $0.17(1) I See Footnotes(12)(14)
Warrant to Purchase Preferred Stock (16) (19) Series C-2 Preferred Stock(21) 2,629(1) $0.17(1) I See Footnotes(13)(14)
Explanation of Responses:
1. Reflects a 1-for-17.2 reverse stock split of the Issuer's outstanding securities effected prior to the effectiveness of the Issuer's S-1 Registration Statement.
2. Shares held by 5AM Ventures II, L.P.
3. Shares held by 5AM Co-Investors II, L.P.
4. 5AM Partners II, LLC is the general partner of 5AM Ventures II, L.P. and 5AM Co-Investors II, L.P. Scott M. Rocklage, a member of the Issuer's board of directors, is a managing member of 5AM Partners II, LLC and may be deemed to have shared voting and investment power over the shares held by 5AM Ventures II, L.P. and 5AM Co-Investors II, L.P. Dr. Rocklage disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
5. The shares subject to the option are early exercisable. 100% of the shares subject to the option vest at the Issuer's Second Annual Meeting post-initial public offering, if any, by December 31, 2014.
6. The shares are immediately convertible.
7. The shares do not have an expiration date.
8. Each share of Series A-1 Preferred Stock will automatically convert on a 1-for-1 basis into Common Stock immediately prior to the closing of the Issuer's initial public offering.
9. Each share of Series B-1 Preferred Stock will automatically convert on a 1.47003745318352-for-1 basis into Common Stock immediately prior to the closing of the Issuer's initial public offering.
10. Each share of Series B-2 Preferred Stock will automatically convert on a 1-for-1 basis into Common Stock immediately prior to the closing of the Issuer's initial public offering.
11. Each share of Series C-1 Preferred Stock will automatically convert on a 1-for-1 basis into Common Stock immediately prior to the closing of the Issuer's initial public offering.
12. Shares held by 5AM Ventures III, L.P.
13. Shares held by 5AM Co-Investors III, L.P.
14. 5AM Partners III, LLC is the general partner of 5AM Ventures III, L.P. and 5AM Co-Investors III, L.P. Scott M. Rocklage, a member of the Issuer's board of directors, is a managing member of 5AM Partners III, LLC and may be deemed to have shared voting and investment power over the shares held by 5AM Ventures III, L.P. and 5AM Co-Investors III, L.P. Dr. Rocklage disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
15. Each share of Series C-2 Preferred Stock will automatically convert on a 1-for-1 basis into Common Stock immediately prior to the closing of the Issuer's initial public offering.
16. This warrant is immediately exercisable.
17. Unless earlier exercised, this warrant shall terminate upon the closing of the Issuer's initial public offering.
18. Immediately prior to the closing of the Issuer's initial public offering, this warrant to purchase shares of Series B-1 Preferred Stock will automatically convert on a 1.47003745318352-for-1 basis into a warrant to purchase shares of Common Stock.
19. This warrant shall automatically net exercise immediately prior to the closing of the Issuer's initial public offering.
20. Immediately prior to the closing of the Issuer's initial public offering, this warrant to purchase shares of Series C-1 Preferred Stock will automatically convert on a 1-for-1 basis into a warrant to purchase shares of Common Stock.
21. Immediately prior to the closing of the Issuer's initial public offering, this warrant to purchase shares of Series C-2 Preferred Stock will automatically convert on a 1-for-1 basis into a warrant to purchase shares of Common Stock.
/s/ Ronald A. Krasnow, as Attorney-in-Fact for Scott M. Rocklage 11/14/2013
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.